Bio-Path (NASDAQ:BPTH – Get Free Report) and Turn Therapeutics (NASDAQ:TTRX – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation. Insider and Institutional Ownership 5.7% of Bio-Path shares […]